COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 78, Issue 2, 2008, Pages 137-146

  Futagami, Seiji ^a   Hiratsuka, Tetsuro ^a   Shindo, Tomotaka ^a   Hamamoto, Tatsuhiko ^a   Tatsuguchi, Atsushi ^a   Nobue, Ueki ^a   Shinji, Yoko ^a   Suzuki, Kenji ^a   Kusunoki, Masanori ^a   Tanaka, Shu ^a   Wada, Ken ^a   Miyake, Kazumasa ^a   Gudis, Katya ^a   Tsukui, Taku ^a   Sakamoto, Choitsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

CCR2; CD40; CD40 ligand; COX 2; Gastric cancer; VEGF

Indexed keywords

CD40 LIGAND; CHEMOKINE RECEPTOR CCR2; CYCLOOXYGENASE 2; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ANALYTIC METHOD; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD40; CD40 LIGAND; CELL LINE; CHEMOKINE CCL2; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MICROCIRCULATION; RECEPTORS, CCR2; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 39849092253     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.10.030     Document Type: Article

References (38)

1. Ohta M., Kitadai Y., Tanaka S., et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int. J. Oncol. 22 (2003) 773-778
2. Salcedo R., Ponce M.L., Young H.A., et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96 (2000) 34-40
3. Mizuno H., Sakamoto C., Matsuda K., et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112 (1997) 387-397
4. Tsujii M., Kawano S., and DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA 94 (1997) 3336-3340
5. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., and DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998) 705-716
6. Tatsuguchi A., Matsui K., Shinji Y., et al. Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum. Pathol. 35 (2004) 488-495
7. Miura S., Tatsuguchi A., Wada K., et al. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblast. Am. J. Physiol. Gastrointest. Liver. Physiol. 287 (2004) G444-G451
8. Zhang Y., Cao H.J., Graf B., Meekins H., Smith T.J., and Phipps R.P. CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts. J. Immunol. 160 (1998) 1053-1057
9. Inoue Y., Otsuka T., Niiro H., et al. Novel regulatory mechanisms of CD40-induced prostanoid synthesis by IL-4 and IL-10 in human monocytes. J. Immunol. 172 (2004) 2147-2154
10. Danese S., Sans M., and Fiocchi C. The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut 53 (2004) 1035-1043
11. Grewal I.S., and Flavell R.A. CD 40 and CD 154 in cell-mediated immunity. Annu. Rev. Immunol. 16 (1998) 111-135
12. Van Kooten C., and Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 67 (2000) 2-17
13. Melter M., Reinders M.E., Sho M., et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96 (2000) 3801-3808
14. Heid C.A., Stevens J., Livak K.J., and Williams P.M. Real time quantitative PCR. Genome Res. 6 (1996) 986-994
15. Futagami S., Hiratsuka T., Tatsuguchi A., et al. Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells. Gut 52 (2003) 1257-1264
16. Mirzadegan T., Diehl F., Ebi B., et al. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists. J. Biol. Chem. 275 (2000) 25562-25571
17. Reul R.M., Fang J.C., Denton M.D., et al. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 64 (1997) 1765-1774
18. Tang K.F., Tan S.Y., Chan S.H., et al. A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages. Hum. Pathol. 32 (2001) 42-49
19. Grunstein J., Roberts W.G., Mathieu-Costello O., Hanahan D., and Johnson R.S. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 59 (1999) 1592-1598
20. Williams C.S., Tsujii M., Reese J., Dey S.K., and DuBois R.N. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest. 105 (2000) 1589-1594
21. Murphy J.F., Steele C., Belton O., and Fitzgerald D.J. Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3. Br. J. Haematol. 121 (2003) 157-164
22. Murphy J.F., Lennon F., Steele C., Kelleher D., Fitzgerald D., and Long A.C. Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and proliferation in human vascular endothelial cells. FASEB J. 19 (2005) 446-448
23. Garlichs C.D., Geis T., Goppelt-Struebe M., et al. Induction of cyclooxygenase-2 and enhanced release of prostaglandinE2 and I2 in human endothelial cells by engagement of CD40. Atherosclerosis 163 (2002) 9-16
24. Tanaka S., Tatsuguchi A., Futagami S., et al. Monocyte chemoattractant protein-1 and macrophage cyclooxygenase-2 expression in colonic adenoma. Gut 55 (2006) 54-61
25. Koide N., Nishio A., Sato T., Sugiyama A., and Miyagawa S. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am. J. Gastroenterol. 99 (2004) 1667-1674
26. Valkovic T., Lucin K., Krstulja M., Dobi-Babic R., and Jonjic N. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol. Res. Pract. 194 (1998) 335-340
27. Ueno T., Toi M., Saji H., et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 6 (2000) 3282-3289
28. Ohta M., Kitadai Y., Tanaka S., et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int. J. Cancer 102 (2002) 220-224
29. Tonouchi H., Miki C., Tanaka K., and Kusunoki M. Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients. Scand. J. Gastroenterol. 37 (2002) 830-833
30. Danese S., Katz J.A., Saibeni S., et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 52 (2003) 1435-1441
31. Buning C., Kruger K., Sieber T., Schoeler D., and Schriever F. Increased expression of CD40 ligand on activated T cells of patients with colon cancer. Clin. Cancer Res. 8 (2002) 1147-1151
32. Danese S., de la Motte C., Sturm A., et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 124 (2003) 1249-1264
33. Lu Y., Cai Z., Xiao G., et al. CCR2 expression correlates with prostate cancer progression. J. Cell. Biochem. 101 (2007) 676-685
34. Liang L., Hu D., Liu W., Williams J.P., Okunieff P., and Ding I. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. Am. J. Clin. Oncol. 26 (2003) S114-S121
35. Zedler R., Csanady M., Gires O., Lang S., Schmitt B., and Wollenberg B. Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1. FASEB J. 14 (2000) 661-668
36. Salcedo R., Zhang X., Young H.A., et al. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood 102 (2003) 1966-1977
37. Thivierge M., Le Gouill C., Tremblay M.J., Stankova J.M., and Rola-Pleszczynski M. Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 92 (1998) 40-45
38. Panzer U., and Uguccioni M. Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines. Eur. J. Immunol. 34 (2004) 3682-3689